# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Martin Luther (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE004-SYN-TD
- Date: 1527-08-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ottilie Brandt-Mensah, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week review of vertigo attacks and low mood, seen the same day in otology. **S**

## History of present illness

Professor Luther returns two weeks after his first visit, on the day of his consultation with Dr. Okafor-Lindqvist. He has kept the attack diary. He had one attack six days ago that began with roaring and fullness in the left ear, then spinning for about three hours with nausea; he lay down, took one meclizine and slept, and the roaring settled back to its usual level by the next morning. No headache, light sensitivity or visual aura came with it. He has had dull headaches on two other days, without dizziness. His mood is still low; he is sleeping five or six hours, feels guilty and joyless, and has had to push himself to write and teach. He has had no thoughts of death or of harming himself. He has never had a period of days with little need for sleep, racing thoughts or unusual energy. **S**

| Element | Detail |
|---|---|
| Attacks | One since intake, three hours, with left-ear roaring and fullness |
| Meclizine | One dose |
| Headache | Two dull headaches without dizziness; none with the attack |
| Mood | Low, guilty, joyless; poor sleep; no thoughts of self-harm |
| Mania screen | No past hypomanic or manic episodes |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Ears, nose, mouth, and throat | Positive | Constant left-ear tinnitus and fullness; muffled hearing on the left |
| Neurological | Positive | One vertigo attack; two dull headaches; no weakness, numbness, double vision or slurred speech |
| Gastrointestinal | Positive | Nausea during the attack; bowels regular |
| Genitourinary | Negative | No flank pain or blood in the urine |
| Psychiatric | Positive | Low mood, guilt, loss of interest, broken sleep; no suicidal ideation |

5 systems reviewed. **S**

## Current medications

- Meclizine 25 mg tablet, one by mouth up to every 8 hours during a severe vertigo attack only, for no more than 3 days at a time **S**
- Hydrochlorothiazide 25 mg tablet, one by mouth each morning **S**
- Sertraline 25 mg tablet, one by mouth each morning for one week **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/80 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 86.2 kg; BMI 28.1 kg/m². All vital signs are synthetic.

PHQ-9: 14. All results are synthetic.

## Change since baseline

- PHQ-9: 15 at baseline, 14 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well-built man; blood pressure 126/80, pulse 74; weight 86.2 kg |
| Ears | Ear canals and tympanic membranes normal; Weber lateralizes to the right; Rinne positive on both sides |
| Neurological | No spontaneous or gaze-evoked nystagmus; head impulse test normal; cranial nerves, coordination and gait normal; Romberg steady |
| Psychiatric | Mood low, affect constricted; speech fluent and forceful; no suicidal ideation; no psychotic features |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Ménière disease of the left ear, definite** (H81.02). The presenting attacks of vertigo with left-ear tinnitus and muffled hearing now have their diagnosis. Dr. Okafor-Lindqvist finds definite Ménière disease of the left ear by the AAO-HNS 1521 and Bárány criteria: more than two spontaneous attacks of spinning vertigo lasting about one to six hours, low-frequency sensorineural hearing loss of 40 dB at 250 and 500 Hz on today's audiogram in the affected ear, and fluctuating tinnitus and fullness in that ear. Vestibular migraine was considered, because he has headaches, but no attack has come with migraine features, so its criteria are not met; the headaches will be recorded in the diary. The examination between attacks is normal, without signs of stroke. **S**
   - Sodium 1,500 to 2,300 mg a day; caffeine down to one cup a day; alcohol limited.
   - Hydrochlorothiazide 25 mg each morning; sodium and potassium in two to four weeks.
   - Meclizine only for severe attacks.
   - MRI of the internal auditory canals with gadolinium.
   - No betahistine.
   - Keep the attack and headache diary.
2. **Major depressive disorder, recurrent, moderate** (F33.1). The presenting low mood now has its diagnosis. On a structured diagnostic interview he has had depressed mood, loss of interest, broken sleep, fatigue, guilt and poor concentration for about two months, with a clear earlier episode in his twenties: major depressive disorder, recurrent, moderate, by DSM-5-TR, with anxious distress about the attacks. No past hypomania or mania, and the Mood Disorder Questionnaire is negative, so an antidepressant is safe to start. PHQ-9 14. The depression is not explained by the vertigo alone, though the attacks feed it. After discussing therapy alone, medicine alone, or both, he chose both. **S**
   - Weekly cognitive behavioral therapy with behavioral activation, adapted to his faith and the fear of attacks.
   - Sertraline 25 mg each morning for a week, then 50 mg.
   - Safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Vertigo attack diary: number, duration, hearing, tinnitus, fullness, headache | Every visit | Completed today | One three-hour attack since intake; two headaches without vertigo; Dizziness Handicap Inventory 52 (moderate) (Dizziness Handicap Inventory in the notes; no LOINC code used) |
| Examination | Audiometry (pure-tone and speech) with tympanometry | At diagnosis; repeat at about three months and with any change in hearing | Completed today | Left low-frequency sensorineural loss of 40 dB at 250 and 500 Hz; word recognition 88 percent left, 100 percent right; normal tympanograms |
| Imaging | MRI of the internal auditory canals with gadolinium | Once, to exclude a retrocochlear lesion with asymmetric hearing loss | Ordered | Ordered today |
| Examination | Vestibular function testing and electrocochleography | Not routinely for diagnosis | Not indicated | The guideline advises against routine testing to diagnose Ménière disease; the history and audiogram are enough |
| Medication safety | Vestibular suppressant use | Every visit | Completed today | One meclizine dose in two weeks; limited to severe attacks |
| Self-management | Sodium, caffeine and alcohol limits | Every visit | Ordered | Education given today |
| Referral | Otology consultation | Once, at diagnosis | Completed today | Seen by Dr. Okafor-Lindqvist today |
| Survey | PHQ-9 | At least monthly during acute treatment | Completed today | 14, from 15 at intake |
| Survey | Mood Disorder Questionnaire at the initial depression workup | Once at the initial workup; repeat if hypomanic features emerge | Completed today | Negative; no past hypomania or mania |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No suicidal ideation, intent or plan; PHQ-9 item 9 scored 0. Safety plan reviewed |
| Medication safety | SSRI tolerability check two weeks after starting | 2 weeks after starting and after each dose change | Ordered | Due in two weeks; with the sodium check on the thiazide |
| Laboratory | Sodium, potassium, creatinine and calcium on a thiazide with an SSRI | Two to four weeks after starting, then every three to six months | Ordered | Sodium and potassium in two to four weeks |

## Goal progress

- Fewer and milder vertigo attacks: no more than one disabling attack a month by three months, and able to preach without fear of an attack. In progress; target 1527-10-27. **S**
- Depression response (PHQ-9 down by at least 50 percent) by three months. In progress; target 1527-10-27. **S**
- Sodium intake below 2,300 mg a day. In progress; target 1528-01-31. **S**
- Urine volume of at least 2.5 liters a day. In progress; target 1528-01-31. **S**

## Medication changes

- Started: Hydrochlorothiazide 25 mg tablet, one by mouth each morning **S**
- Started: Sertraline 25 mg tablet, one by mouth each morning for one week **S**

## Guideline basis

- Clinical Practice Guideline: Ménière's Disease (2020), American Academy of Otolaryngology-Head and Neck Surgery Foundation (Basura GJ, et al. Otolaryngol Head Neck Surg 2020;162(2 Suppl):S1-S55)
- Diagnostic criteria for Menière's disease (2015), Bárány Society Classification Committee (Lopez-Escamez JA, et al. J Vestib Res 2015;25(1):1-7)
- Vestibular migraine: diagnostic criteria (update) (2022), Bárány Society and International Headache Society (Lempert T, et al. J Vestib Res 2022;32(1):1-6)
- Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial) (2016), BMJ (Adrion C, et al. BMJ 2016;352:h6816)
- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Blood test in two to four weeks. Review in six weeks. **S**
- Next scheduled visit 1527-09-08: periodic adult preventive visit. **S**
